Ambroxol
Mucolytic
What it is used for
Respiratory disorders associated with viscid or excessive mucus. Clinical selection for Ambroxol should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Mucolytic. Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Obtain allergy and medication history. Adjust for renal/hepatic impairment, pregnancy, lactation, extremes of age and interacting drugs. Use the lowest effective dose for the shortest appropriate duration. Monitor for expected class adverse effects.
Possible side effects
Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.